share_log

Climb Bio Signs Deal With Beijing Mabworks Biotech to Develop Antibody for IgA Nephropathy

Climb Bio Signs Deal With Beijing Mabworks Biotech to Develop Antibody for IgA Nephropathy

Climb Bio與天廣實生物-B(臨時代碼)簽訂協議,以開發針對IgA腎病的抗體
MT Newswires ·  01/09 17:27

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 252

熱點推薦

搶先評論

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。